| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-12 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
Enrollment reduced: 123 -> 21 participants |
| 2026-06-04 | NCT06581198 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus… |
Trial sites expanded: 93 -> 101 locations |
| 2026-05-23 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
date change Completion moved earlier: 2033-02-06 -> 2032-11-29 |
| 2026-05-21 | NCT06868290 Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA… |
Trial sites expanded: 31 -> 35 locations |
| 2026-05-21 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
Trial sites expanded: 58 -> 67 locations |
| 2026-05-16 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
Trial sites expanded: 55 -> 58 locations |
| 2026-05-16 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
date change Primary completion moved earlier: 2029-07-17 -> 2029-03-09 |
| 2026-05-16 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
date change Completion pushed: 2030-07-17 -> 2033-02-06 |
| 2026-05-14 | NCT06655896 Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous… |
Trial sites expanded: 80 -> 87 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06868290 | Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA… | ANCA Associated Vasculitis (AAV) | Recruiting |
| NCT06581198 | A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus… | Lupus Erythematosus, Systemic | Recruiting |
| NCT06655896 | Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous… | Scleroderma, Diffuse | Recruiting |
| NCT06665256 | Phase 2 Study of Rapcabtagene Autoleucel in Myositis | Idiopathic Inflammatory Myopathies | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07048197 | A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene… | Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD) | Recruiting |
| NCT06617793 | An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in… | Relapsing Multiple Sclerosis | Recruiting |
| NCT05798117 | An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in… | Systemic Lupus Erythematosus | Active, Not Recruiting |
| Phase 1 | |||
| NCT07443137 | CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) | Large-cell Lymphoma | Not Yet Recruiting |